Answers from the Lab

Maria Alice Willrich, Ph. D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's disease. (00:32)  Do you mind giving the audience more information about yourself and your background?   (01:53)  Could you please give a brief overview of this...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph. D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to discuss tick-borne diseases and the latest testing options. Specific topics of discussion include: The types of tick-borne diseases found throughout the United...

Alicia Algeciras-Schimnich, Ph. D., discusses how Mayo Clinic Laboratories’ new noninvasive blood test for Alzheimer’s disease identifies the p-tau217 biomarker, which is associated with the accumulation of amyloid beta in the brain. Positive test results can facilitate access to disease-modifying therapies.  (00:32): Dr. Algeciras, could you just provide a little bit of background on your role at...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They discuss current events including dengue outbreaks, new colon cancer screening technology, and insurance coverage of innovative lab tests. Their discussion includes: The sur...

Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing. (00:33)  Do you mind giving us a brief introduction of yourself and what you do at Mayo?   (01:45)  Can you tell us a little about the test and how it came to be?...

The Centers for Disease Control and Prevention (CDC) issued a recent health advisory in response to the increasing number of measles outbreaks in the United States. In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph. D., professor of laboratory medicine and pathology and clinical virol...

Linda Hasadsri, M.D., Ph. D., and Huong T. Cabral, M.S., C.G.C., explain how Mayo Clinic Laboratories' targeted test panel facilitates accurate diagnosis of hereditary pancreatitis, which heightens the risk for pancreatic cancer. Test results can guide cancer monitoring for patients and their families. (00:33)  Dr. Hasadsri, can you tell the audience a little bit about yourself and your background...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They discuss important industry updates and legislative insights gathered from Dr. Morice’s recent trip to Washington, D.C. Their discussion includes: The status of current labo...

Wei Shen, Ph. D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide cancer surveillance for patients and their families. (00:32)  Would each of you share a little bit about yourselves and your background? Dr. Shen?   (01:25)  Rihanna, could we have you give a...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph. D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to follow up on the syphilis epidemic and discuss updated testing recommendations. Specific topics of discussion include: Background information on syphilis and th...

Paul Jannetto, Ph. D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients in substance-use cessation programs and other settings. The serum and urine tests quantify nicotine and various metabolites. (00:32)  Can you tell us a little bit about yourself and your background?   (01:42)  Can you please provide an overview of substance use disorders, specifically nicotine dependen...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories. They discuss the Food and Drug Administration’s (FDA) progress on making a final rule around regulating laboratory-developed tests (LDTs).  Their discussion includes: How the FD...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to honor Black History Month. They reflect on important advancements in healthcare and laboratory medicine that were led by Black healthcare professionals and scholars. They als...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Stefan Grebe, M.D., Ph. D., co-director of the Clinical Mass Spectrometry and Test Development Laboratory in the Department of Laboratory Medicine and Pathology, and Irina Bancos, M.D., consultant in the Division of Endocrinology, Diabetes, and Metabolism w...

Ann Moyer, M.D., Ph. D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy for patients, who might be as young as age 2. (00:32)  Could you please tell us a little bit about your background?   (01:17)  Could you please do a brief overvi...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to discuss current activity of infectious diseases. Their discussion includes: Vector-borne diseases that are causing public health concerns, and the multi-agency public health...

Anne Tebo, Ph. D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune liver disease. (00:32) Could you please provide a little information about your background?   (02:09) Please give a brief overview of the new test panels.   (...

David Murray, M.D., Ph. D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the blood proteins, for improved patient care and simpler test ordering. (00:32) Could you provide us with a little bit about yourself and your background?   (02:...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to discuss what companies in the healthcare and diagnostics industries are focusing on in 2024. Their discussion includes: Insights from the J.P. Morgan Healthcare Conference, a...

Joshua Bornhorst, Ph. D., explains how Mayo Clinic Laboratories' unique blood test identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal health. Speaker 3: (00:32) Can you share a little about yourself and your background?   Speaker 3: (01:00) Can you provide us with an overview of this new...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph. D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to talk about the sexually-transmitted disease syphilis.  Specific topics of discussion include: The history, cause, and symptoms of syphilis. A rare recent outbre...

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph. D., CEO and president of Mayo Clinic Laboratories, to welcome the new year and discuss the increase of respiratory viruses. Their discussion includes: The increasing number of COVID-19 and influenza cases across the United State...

Jeff Meeusen, Ph. D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk. Show notes (00:31) Could you provide us a little bit about your background?   (01:20) Could you give us a brief overview of this assay?   (02...

Robin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these infections. Show notes Speaker 3: (00:32)  Please give us a brief introduction of yourself and your role at Mayo Clinic.   Speaker 3: (01:44)  Could you please expand...

Linnea Baudhuin, Ph. D., and Kate Kotzer, M.S., CGC, describe how Mayo Clinic Laboratories' postmortem genetic tests can provide answers after a sudden unexplained cardiac death. Test results are important for managing family members' risk for cardiovascular disease. Show notes (00:32)  Would each of you share a little bit about yourselves and your backgrounds?   (01:13)  Could you provide us with...